Bioventix
Save
–
Market cap
28.16x
Current P/E
29.67x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services.
Similar securities
Based on sector and market capitalization
Report issue